<https://rdf.molmedb.upol.cz/reference/ref3440> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM490640>,
		<https://identifiers.org/molmedb/MM490641>;
	<http://purl.org/ontology/bibo/doi> "10.1039/c7md00568g"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490642>,
		<https://rdf.molmedb.upol.cz/interaction/membrane21>;
	<http://purl.org/ontology/bibo/pmid> "30108938"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Chough C, Lee S, Joung M, Lee J, Kim JH, Kim BM.: Design, synthesis and evaluation of (<i>R</i>)-3-(7-(methyl(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. Medchemcomm, Volume 9 (3), 2018"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1024269> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
<https://rdf.molmedb.upol.cz/interaction/int1024272> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
<https://rdf.molmedb.upol.cz/interaction/int1024270> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
<https://rdf.molmedb.upol.cz/interaction/int1024274> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
<https://rdf.molmedb.upol.cz/interaction/int1024273> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
<https://rdf.molmedb.upol.cz/interaction/int1024271> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3440> .
